AngioDynamics, Inc. (ANGO)
15.11
-0.01
(-0.07%)
USD |
NASDAQ |
Oct 02, 16:00
15.12
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Price to Book Value : 3.688 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.688 |
| October 01, 2026 | 3.691 |
| September 30, 2026 | 3.754 |
| September 29, 2026 | 3.808 |
| September 28, 2026 | 3.794 |
| September 25, 2026 | 3.781 |
| September 24, 2026 | 3.73 |
| September 23, 2026 | 3.786 |
| September 22, 2026 | 3.825 |
| September 21, 2026 | 3.764 |
| September 18, 2026 | 3.769 |
| September 17, 2026 | 3.752 |
| September 16, 2026 | 3.774 |
| September 15, 2026 | 3.828 |
| September 14, 2026 | 3.786 |
| September 11, 2026 | 3.728 |
| September 10, 2026 | 3.720 |
| September 09, 2026 | 3.740 |
| September 08, 2026 | 3.715 |
| September 04, 2026 | 3.710 |
| September 03, 2026 | 3.776 |
| September 02, 2026 | 3.813 |
| September 01, 2026 | 3.872 |
| August 31, 2026 | 3.938 |
| August 28, 2026 | 3.869 |
| Date | Value |
|---|---|
| August 27, 2026 | 3.852 |
| August 26, 2026 | 3.830 |
| August 25, 2026 | 3.894 |
| August 24, 2026 | 3.850 |
| August 21, 2026 | 3.845 |
| August 20, 2026 | 3.862 |
| August 19, 2026 | 3.923 |
| August 18, 2026 | 3.862 |
| August 17, 2026 | 3.825 |
| August 14, 2026 | 3.869 |
| August 13, 2026 | 3.823 |
| August 12, 2026 | 3.845 |
| August 11, 2026 | 3.845 |
| August 10, 2026 | 3.845 |
| August 07, 2026 | 3.830 |
| August 06, 2026 | 3.688 |
| August 05, 2026 | 3.671 |
| August 04, 2026 | 3.708 |
| August 03, 2026 | 3.703 |
| July 31, 2026 | 3.610 |
| July 30, 2026 | 3.606 |
| July 29, 2026 | 3.571 |
| July 28, 2026 | 3.501 |
| July 27, 2026 | 3.335 |
| July 24, 2026 | 3.318 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Boston Scientific Corp. | 2.472 |
| Penumbra, Inc. | 8.171 |
| Abbott Laboratories | 3.301 |
| Alphatec Holdings, Inc. | -- |
| AtriCure, Inc. | 5.431 |
Price to Book Value Related Metrics
| PS Ratio | 1.959 |
| PEG Ratio | -2.686 |
| Price | 15.11 |
| Earnings Yield | -5.86% |
| Market Cap | 630.09M |
| PEGY Ratio | -2.686 |